JP2016501211A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501211A5
JP2016501211A5 JP2015544484A JP2015544484A JP2016501211A5 JP 2016501211 A5 JP2016501211 A5 JP 2016501211A5 JP 2015544484 A JP2015544484 A JP 2015544484A JP 2015544484 A JP2015544484 A JP 2015544484A JP 2016501211 A5 JP2016501211 A5 JP 2016501211A5
Authority
JP
Japan
Prior art keywords
group
alkyl
halo
alkylene
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015544484A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501211A (ja
Filing date
Publication date
Priority claimed from GB201300649A external-priority patent/GB201300649D0/en
Application filed filed Critical
Priority claimed from PCT/EP2013/075107 external-priority patent/WO2014083163A1/en
Publication of JP2016501211A publication Critical patent/JP2016501211A/ja
Publication of JP2016501211A5 publication Critical patent/JP2016501211A5/ja
Pending legal-status Critical Current

Links

JP2015544484A 2012-11-30 2013-11-29 三環性インドールを得るためのハロゲン化亜鉛による環化プロセス Pending JP2016501211A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN3690/DEL/2012 2012-11-30
IN3690DE2012 2012-11-30
GB1300649.9 2013-01-15
GB201300649A GB201300649D0 (en) 2013-01-15 2013-01-15 Cyclization
PCT/EP2013/075107 WO2014083163A1 (en) 2012-11-30 2013-11-29 Zinc halide mediated cyclization process leading to tricyclic indoles

Publications (2)

Publication Number Publication Date
JP2016501211A JP2016501211A (ja) 2016-01-18
JP2016501211A5 true JP2016501211A5 (enExample) 2017-01-12

Family

ID=49681038

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015544484A Pending JP2016501211A (ja) 2012-11-30 2013-11-29 三環性インドールを得るためのハロゲン化亜鉛による環化プロセス

Country Status (12)

Country Link
US (1) US9475769B2 (enExample)
EP (1) EP2925723A1 (enExample)
JP (1) JP2016501211A (enExample)
KR (1) KR20150088803A (enExample)
CN (1) CN104797559A (enExample)
AU (1) AU2013351126B2 (enExample)
BR (1) BR112015012401A2 (enExample)
CA (1) CA2889642A1 (enExample)
IN (1) IN2015DN03939A (enExample)
MX (1) MX2015006864A (enExample)
RU (1) RU2647867C2 (enExample)
WO (1) WO2014083163A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2310250A1 (en) 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
US7160909B2 (en) 2001-08-09 2007-01-09 Eli Lilly And Company Cyclopenta[b]indole derivatives as sPLA2 inhibitors
ATE312817T1 (de) 2001-08-09 2005-12-15 Lilly Co Eli Cyclohept'bö indolderivate als spla2-inhibitoren
GB0905328D0 (en) 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives

Similar Documents

Publication Publication Date Title
JP2016531121A5 (enExample)
JP2014526533A5 (enExample)
JP2019524861A5 (enExample)
JP2015042636A5 (ja) 有機化合物
JP2012526842A5 (enExample)
JP2012515776A5 (enExample)
RU2013147400A (ru) Способ получения производных кето-бензофурана
EP4329431A3 (en) Novel heteroleptic iridium complexes
RU2015145784A (ru) Способ получения циклоалкилкарбоксамидо-индольных соединений
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
RU2017123807A (ru) Пиколинамиды с фунгицидной активностью
JP2016540742A5 (enExample)
JP2007523139A5 (enExample)
JP2015537008A5 (enExample)
JP2013543842A5 (enExample)
JP2015530408A5 (enExample)
EP3388426A3 (en) Compounds for protection of cells
MX395406B (es) Compuestos de piperidinobenzodiazepina con actividad antiproliferativa.
PH12017501652A1 (en) Kv1.3 inhibitors and their medical application
RU2017144050A (ru) Способ синтеза производных рапамицина
JP2017515919A5 (enExample)
JP2013136631A5 (enExample)
JP2015500842A5 (enExample)
JP2012254971A5 (ja) カルバゾール化合物
RU2014129937A (ru) Способы и промежуточные соединения для получения фармацевтических агентов